iiinova — where your digital self keeps evolving

M Velia Antonini @foamecmo.bsky.social · 06/10/2026

Pulmonary arterial pressure in VA #ECMO for patients with acute cardiogenic shock? 🔍 > 7.6K adults with CS from the ELSO Registry, 2015 - 2020; >3K managed with PACs 🖥️ Early on-support PAD potentially important hemodynamic marker during VA #ECLS. 🖇️ bit.ly/4hH8ysu

010

Reposted by M Velia Antonini

esottransplant @esottransplant.bsky.social · 04/10/2026

🌍 𝗡𝗼𝗻-𝗘𝘂𝗿𝗼𝗽𝗲𝗮𝗻 𝘁𝗿𝗮𝗻𝘀𝗽𝗹𝗮𝗻𝘁 𝗽𝗿𝗼𝗳𝗲𝘀𝘀𝗶𝗼𝗻𝗮𝗹𝘀: advance your learning with ESOT in 2027. Only 5️⃣ 𝗜𝗻𝘁𝗲𝗿𝗻𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗟𝗲𝗮𝗿𝗻𝗶𝗻𝗴 𝗚𝗿𝗮𝗻𝘁𝘀 are available; all disciplines are welcome. ✓ Registration waived ✓ Up to €2,000 travel support Start your application today. 👉 go.esot.org/EGP27_02 #ESOTgrants

111

M Velia Antonini @foamecmo.bsky.social · 24/09/2026

Membrane lung dead space in #ECMO: related with failure? 📦 circuits requiring replacement had higher MLDS + lower CO2 in exhaust gas + ML CO2 removal MLDS could be associated with other performance indicators (as resistances), contributing to better understanding of ML physiology 🔓 bit.ly/4yUDVqr

000

M Velia Antonini @foamecmo.bsky.social · 23/09/2026

The (influential) role of regret in #ECMO candidacy decision-making may partly explain known inconsistencies in candidacy decisions within centers?? 🖇️ bit.ly/3TeJ5yt

020

Reposted by M Velia Antonini

theelso.bsky.social @theelso.bsky.social · 22/09/2026

📢 The 3 SWAAC ELSO 2026 research webinar sessions are now available to watch on demand! What you'll take?? 🎥 1️⃣ Foundations of #ECLS research & epidemiology 🎥 2️⃣ ELSO Registry: structure, access, research use 🎥 3️⃣ ECLS Research in low-and middle-income countries Open #FOAMcc #FOAMecmo 🖇️ bit.ly/4rv2bx4

021

Reposted by M Velia Antonini

theelso.bsky.social @theelso.bsky.social · 21/09/2026

📢 Spring training opportunities! Adult #ECMO #simulation course: 🛠️ hands on learning + 🚧 troubleshooting, two 1 ½ day sessions 📆 April 12-13 or April 14-15 2027 🎓 Cannulation course: 1 day hands-on sessions 📆 April 16 or 17 or 18, 2027 ELSO headquarters 📌 Ann Arbor MI Register 🎓 bit.ly/ELSOAcademy

021

M Velia Antonini @foamecmo.bsky.social · 20/09/2026

Data confirms clinically meaningful survival advantage for #ECMO in refractory shockable #OHCA. Faster cannulation is associated with survival, and prehospital & hybrid delivery models increase access to ECLS. In parallel, individualized selection complements time-targeted delivery. 🖇️ bit.ly/4iF63Jk

010

M Velia Antonini @foamecmo.bsky.social · 18/09/2026

Accessibility to #ECPR pathway for o#OHCA?? Still limited! Timely access to #ECMO essential to improve CA outcomes: developing an effective & equitable system requires multidisciplinary collaboration to ensure access is maximised while preserving time-sensitive benefits. 🖇️ bit.ly/4hlPUGC

002

Reposted by M Velia Antonini

esottransplant @esottransplant.bsky.social · 18/09/2026

⏳ Have you explored the #ESOTgrants Programme 2027 yet? There may be a grant designed for you. 🗓️ Deadline: 𝟲 𝗢𝗰𝘁𝗼𝗯𝗲𝗿 𝟮𝟬𝟮𝟲 Invest in your future. ESOT is ready to invest in you. #PoweredByESOT #Transplantation #ESOTeducation #Research

go.esot.org

Grants programme 2027 • ESOT

#ESOTgrants applications are open till 6 October.

021

M Velia Antonini @foamecmo.bsky.social · 16/09/2026

Optimal criteria for #ECPR patient selection remain poorly understood: should be center-specific reflecting resources and readiness. However, findings of this study support inclusion of lactate/pH as part of multifactorial risk tools to guide risk assessment/decision-making when evaluating candidacy

000

Reposted by M Velia Antonini

theelso.bsky.social @theelso.bsky.social · 14/09/2026

📖 Mechanical complications & crisis management. Blue book - chapter 28: 🫁 ML dysfunction/failure 💨 interruption of gas supply ⚙️ pump failure 🫧 air entrainment 🩸 circuit disruption 🩸 inadvertent decannulation 📘 Latest edition of ELSO #ECMO Specialist Training Manual is available 🛒 bit.ly/ELSObooks

011

M Velia Antonini @foamecmo.bsky.social · 14/09/2026

📖 Mechanical complications & crisis management. The oversight, provision, delivery of #ECMO has often been compared to phrase: hours and hours of boredom interspersed by moments of stark terror.Take a look at Chapter 28 of the 📘 Blue Book: the ELSO #ECMO Specialist Training Manual 🛒 bit.ly/ELSObooks

011

M Velia Antonini @foamecmo.bsky.social · 13/09/2026

📢 2026 @aatshq.bsky.social consensus on antithrombotics in neonates/infants undergoing 🫀 interventions 🩸 hemostatic system 🩸 CPB & catheter-based intervention 🫀 shunt physiology 🚰 conduits/baffles/nonautologous patch 🫀 interventional cardiology 🫀 bridging therapy 🩺 CVC 🫀 VR #PedsICU 🖇️ bit.ly/4gOxuiC

011

M Velia Antonini @foamecmo.bsky.social · 12/09/2026

High-risk acute pulmonary embolism? VA #ECLS with early percutaneous or surgical embolectomy may provide a survival benefit over #ECMO alone 🫀🫁 Optimal outcomes will likely be achieved through integrated approach combining #MCS with prompt thrombus removal. @asaiojournal.bsky.social 🖇️ bit.ly/4xof6lH

011

M Velia Antonini @foamecmo.bsky.social · 11/09/2026

📢 Cowboy cannulation and simulation showdown hands-on activity at #ELSO2026 37th Annual @theelso.bsky.social Conference‼️

011

M Velia Antonini @foamecmo.bsky.social · 10/09/2026

Circuit thrombosis & mechanical failure in children in #ECMO ⚠️ circuit failure common: 19% with at least one circuit replacement in 15% of runs ⏱️ median time to failure 129.5h 🪦 significantly increased mortality (49% vs 34%), strongest effect in neonates @asaiojournal.bsky.social 🖇️ bit.ly/4hkvYos

001

M Velia Antonini @foamecmo.bsky.social · 09/09/2026

Recording of #SEECMO2026 webinar:🩸 Hemolysis in #ECMO⁉️ More than just a laboratory finding is available 🔍 Clinical impact, pathophysiology, biomarkers of hemolysis 🩺 Cannulation strategies, patient management, real-world cases ⚙️ Circuit-related causes, troubleshooting, prevention 🎥 bit.ly/3SVydoP

010

M Velia Antonini @foamecmo.bsky.social · 08/09/2026

Prolonged #ECMO in children with respiratory failure: any likelihood of native lung recovery? 🫁 Duration alone should not be sole determinant of poor prognosis: other clinical factors + presence of complications more relevant ! Should prolonged ECMO definition of be set at 28 days? 🖇️ bit.ly/4heWBey

062

Reposted by M Velia Antonini

esottransplant @esottransplant.bsky.social · 08/09/2026

Not separate sessions. 𝗢𝗻𝗲 𝗰𝗼𝗻𝗻𝗲𝗰𝘁𝗲𝗱 𝗽𝗿𝗼𝗴𝗿𝗮𝗺𝗺𝗲. What makes this meeting different is how it’s built. It is designed to help you step back, connect the dots, and return to practice with a broader view. 📅 1 - 3 December | Barcelona Important: 14 Sep - Abstract submission deadline

go.esot.org

Programme at a glance

011

Reposted by M Velia Antonini

theelso.bsky.social @theelso.bsky.social · 07/09/2026

⏳ - 21 to #ELSO2026... 🪑 preconference sessions, debates/case based discussion & roundtables 🎤 2 main congress plenary sessions 🫀🫁🔬🍼🧸 28 breakout sessions 📊 11 abstract sessions 📦 3 sponsored talks 🏅 Awards Ceremony & much more! 📆 Sep 28 - Oct 1 📌 Nashville, TN Full program at 🖇️ bit.ly/ELSO2026

021

M Velia Antonini @foamecmo.bsky.social · 06/09/2026

My position as ICM social media Editor ended with at the end of 2024 when the EiC changed... sorry

120

Reposted by M Velia Antonini

esottransplant @esottransplant.bsky.social · 05/09/2026

The ESOT Research Hub is your central gateway to the latest open surveys across the ESOT community 𝗪𝗵𝘆 𝘁𝗮𝗸𝗲 𝗽𝗮𝗿𝘁? Every response contributes to a broader understanding of transplantation today. Explore the ESOT Research Hub and add your perspective. #PoweredByESOT #TransplantResearch

go.esot.org

ESOT Research Hub | Open Surveys

Contribute your insights today to help shape the future of transplantation

011

Reposted by M Velia Antonini

theelso.bsky.social @theelso.bsky.social · 05/09/2026

📖 Blue book chapter 27 focuses on medical complications, offering clinicians strategies to anticipate, detect, mitigate their effects in #ECLS 🩸 Bleeding/thrombosis, hemolysis, thrombocytopenia 🧫 Infections 🦵🏻 Limb ischemia 🫀 Cardiac tamponade 🫁 PTX & hemothorax 🫘 AKI 🧠 Seizures 🛒 bit.ly/ELSObooks

031

M Velia Antonini @foamecmo.bsky.social · 04/09/2026

🫁 ECCO₂R-facilitated early extubation using modern device with capacity to eliminate > 50% of average CO2 production, may be associated with shorter IMV/NIV. Trends favored ECCO2R across several secondary outcomes. Small sample/premature termination = hypothesis-generating. 🔓 rdcu.be/1VFntAnk7eFa

011

Reposted by M Velia Antonini

theelso.bsky.social @theelso.bsky.social · 03/09/2026

📱 Did you download the ELSO's #ECMO Bedside Guide ⁉️ The essential, free guide for managing #ECMO patients: ⚖️ assess candidacy 📦 equipment 📋 checklists 🧮 calculators 💉 medications in #ECLS 📚 resources and the amazing ⚠️ Panic button Apple 📱 bit.ly/ELSOBedsideG... Android 📱 bit.ly/ELSOBedsideG...

021

Reposted by M Velia Antonini

theelso.bsky.social @theelso.bsky.social · 02/09/2026

Long-term mortality & outcomes in adults treated with #ECMO 🔍 SR/MA: 163 studies/>78K pts 🪦 long-term mortality remains high with substantial variation by modality/indication, from 37% for VV to 74% for ECPR at 1y 📚 functional outcomes inconsistently reported only in 23% of studies 🖇️ bit.ly/3SDFuK3

021

Reposted by M Velia Antonini

esottransplant @esottransplant.bsky.social · 01/09/2026

One month left to submit your abstract to the 16th #EPITAsymposium. Submitters are eligible for: 🏆 Best Oral Presentation - €500 🏆 Best Poster - €250 🏆 Best Pitch - 12-month ESOT membership ⏳ Deadline: 1 October 2026 Submit: go.esot.org/epitasymp27_00 #ESOT_EPITA

011

Reposted by M Velia Antonini

theelso.bsky.social @theelso.bsky.social · 31/08/2026

🍂 Advance your #ECMO expertise this fall in Ann Arbor, MI! Adult simulation course 📆 Nov 9-10 🚦 Nov 11-12: full - waitlist available Neo/Peds simulation course 📆 Oct 13-14 Adult cannulation workshop 📆 Oct 11 📆 Nov 15 🚦 Oct 10/Nov 13/Nov 14: full - waitlist available 📌 Ann Arbor 🎓 bit.ly/ELSOAcademy

031

M Velia Antonini @foamecmo.bsky.social · 29/08/2026

LV unloading in VA #ECMO for refractory CS 🫀 non-selective approach may expose pt to unnecessary risks without improving outcomes; meaningful benefits in carefully selected pt phenotypes cannot be excluded. Results of ongoing RCTs awaited to define optimal unloading strategies 🔓 rdcu.be/gXGJHYxag6Da

021

M Velia Antonini @foamecmo.bsky.social · 27/08/2026

Obesity paradox in VV #ECMO?? BMI seems a continuous risk factor for risk stratification, counseling, and complication mitigation. Absence of a futility threshold reinforces that BMI alone should not be considered absolute exclusion criterion for VV #ECMO @asaiojournal.bsky.social 🖇️ bit.ly/3UD4r8T

022

M Velia Antonini @foamecmo.bsky.social · 26/08/2026

The unknown "others" of neonatal respiratory #ECLS?? 🫁 As ECMO use continues to provide an important life-saving therapy for critically ill neonates with cardiopulmonary failure, more diagnosis-specific data needed to better understand outcomes. @asaiojournal.bsky.social 🖇️ bit.ly/45Qeg5P

012

M Velia Antonini @foamecmo.bsky.social · 24/08/2026

Preoperative #ECMO stabilization in pts with cardiogenic shock secondary to valvular dysfunction: from traditional VA to LAVA #ECLS 🌋 Principal advantage of LAVA circulatory support + effective left-sided decompression, as bridge to surgical replacement @asaiojournal.bsky.social 🖇️ bit.ly/4wIaI0j

012

M Velia Antonini @foamecmo.bsky.social · 23/08/2026

🩸 Hemolysis in #ECMO⁉️ More than a laboratory finding... Join #SEECMO2026 webinar 🖥️. 🔍 Clinical impact, pathophysiology, biomarkers, G Peek 🩺 Cannulation strategies, management, C Harvey ⚙️ Circuit causes, troubleshooting, prevention, MV Antonini 📆 Sep 1 ⏰ 9- 10 am EDT Register at 🔓 bit.ly/4ghvEqk

000

M Velia Antonini @foamecmo.bsky.social · 21/08/2026

🚑 #ECMO increasingly used for refractory #OHCA, with survival up to ≈30% in select highly organized systems: evolving data indicate outcomes driven largely by system performance, depending on local adaptation, high-volume, rigorous training, continuous quality improvement, integration of economics.

011

Reposted by M Velia Antonini

theelso.bsky.social @theelso.bsky.social · 19/08/2026

📢 Join 4️⃣ ELSO Registry live Q&A. Bring questions about ❓data definitions/interpretation ❓challenging or complex cases ❓common data-entry questions/uncertainties 📅 Sep 9, 2026 ⏰ 8-9 AM EDT 🖥️ virtual meeting, live Q&A 🔓 no registration required 🔗 bit.ly/4gpjxWY

021

M Velia Antonini @foamecmo.bsky.social · 18/08/2026

Characterization of ventilator-associated pneumonia in patients receiving #ECMO VAP common: incorporation of #ECLS settings (sustained SGF ⬆️) into composite definition may improve recognition of respiratory deterioration & VAP detection sensitivity. #FOAMcc @asaiojournal.bsky.social 🔓 bit.ly/4xdTbOY

011

Reposted by M Velia Antonini

theelso.bsky.social @theelso.bsky.social · 17/08/2026

#ELSO2026: let's make some reflections during final plenary session moderated by Congress Chair, N Rintoul 🔮 Future vision of ECMO - P Alexander/R Lorusso 🔮 #ECMO then & now: from vision to reality - T Mueller 📰 ELSO updates: CEO remarks - C Stead 📌 Nashville, TN 📆 Sep 28 - Oct 1 🖇️ bit.ly/ELSO2026

021

M Velia Antonini @foamecmo.bsky.social · 15/08/2026

Loss of pulsatility after #ECPR? 🔎 221 pts (2011 - 2024), high volume center 🖥️ loss of pulsatility = any PP = 0 during first 12 h after #ECMO 🖥️ at least 1️⃣ episode in nearly 50%. Pts had: ⚖️ llonger CA-to-ECMO ⚖️ higher mortality; each hour of loss of pulsatility increased risk 🔓 bit.ly/4wsKkrm

011

M Velia Antonini @foamecmo.bsky.social · 14/08/2026

sNO in anticoagulation-contraindicated adult #ECMO to provide localized antiplatelet activity at blood-circuit interface without intentional systemic anticoagulation? 💨 20 ppm via ML SGF pathway for 2–72 days 🩸 no sNO-attributable safety events/complications @asaiojournal.bsky.social 🖇️ bit.ly/4wvJpq

012

M Velia Antonini @foamecmo.bsky.social · 10/08/2026

#ECPR deployment in the emergency department setting for pediatric #IHCA: feasible but rare, one-in-20: are there missed opportunities beyond the median of one case per year?? 🖇️ bit.ly/4xu01iN

000

M Velia Antonini @foamecmo.bsky.social · 09/08/2026

Any true benefit associated with TTM post CA? 📚 discussing its (flawed??) foundation, looking at available evidence: why TTM efficacy receded? 🧊 how we moved up optimal target, up to fever control 🌡️? ⏱️ why cooling period had contracted? 🫀 does population matter? @emcrit.bsky.social 🔓 bit.ly/4wmjMrR

000

Reposted by M Velia Antonini

theelso.bsky.social @theelso.bsky.social · 06/08/2026

📖 Patient advocacy & helping families! Here chapter 26 of the The Blue Book #HumanizeICU 🛟 Supporting patients/families ⚖️ Ethical concerns 💪🏼 Rehabilitation and role of #ECLS specialist 📘 Latest edition of ELSO #ECMO Specialist Training Manual is available in our online bookstore! 🛒 bit.ly/ELSObooks

021

M Velia Antonini @foamecmo.bsky.social · 05/08/2026

Beating the odds: survival after #ECMO decannulation due to poor prognosis in #PedsICU? Recovery rare but possible! Prognostication in #ECLS uncertain; individualized, multidisciplinary, family-centered decision-making pivotal as considering discontinuation @asaiojournal.bsky.social 🖇️ bit.ly/458VYwh

011

M Velia Antonini @foamecmo.bsky.social · 04/08/2026

Cerebro‑cardiovascular coupling in #ECMO? Monitoring pivotal for neuroprotective management! 🔍 study evaluating cerebral hemodynamics in adults with CS on VA #ECLS 🖥️ Combined TCD + rSO2 offers insight into cerebral perfusion & cardiac performance/recovery @asaiojournal.bsky.social 🖇️ bit.ly/4w9slWN

022

M Velia Antonini @foamecmo.bsky.social · 01/08/2026

Early rehabilitation in patients in VV #ECMO as bridge to recovery 💪🏼 consistent #ICURehab exposure may serve primarily as marker of physiologic stability/resilience + recovery potential, and may reflect potentially modifiable therapeutic exposure in ECLS. @asaiojournal.bsky.social 🖇️ bit.ly/3REOf67

001

M Velia Antonini @foamecmo.bsky.social · 31/07/2026

🚑 Decannulation success after #ECMO in #OHCAdepends on multiple interrelated factors, bedside-assessable & noninvasive. Optimizing modifiable factors as myocardial recovery, vasopressor requirements, blood flow requirements could improve decannulation outcomes. #FOAMcc #FOAMecmo 🖇️ bit.ly/4h8EcjY

001

M Velia Antonini @foamecmo.bsky.social · 29/07/2026

Micro-axial flow pump vs VA #ECMO for high-risk PCI 🫀 pts w complex three-vessel disease, unprotected left main coronary disease or last patent conduit + LVEF ≤35% mAFP non-inferior to ECMO for major adverse events + shorter post-procedural LoS/fewer device-related adverse events 🖇️ bit.ly/4pIr9YF

011

M Velia Antonini @foamecmo.bsky.social · 27/07/2026

OD following MAiD: recommendations of Transplantation Society providing guidance to support end-of-life wishes while safeguarding ethical/legal standards, and maintaining trust in MAiD & #transplantation: ⚖️ regulatory safeguards 📋 clinical pathway 🔑 key ethical considerations 🔓 bit.ly/4hAZuqx

010

M Velia Antonini @foamecmo.bsky.social · 27/07/2026

📖 Procedures on #ECMO??:#ECLS should not be considered a barrier to any intervention or surgery! With proper planning, a broad range of procedures can be safely managed during the run! 📘 The Blue Book: latest edition of @theelso.bsky.social #ECMO Specialist Training Manual 🛒 bit.ly/ELSObooks

000

Reposted by M Velia Antonini

theelso.bsky.social @theelso.bsky.social · 24/07/2026

Celebrating Dr. Bartlett at #ELSO2026, 37th annual conference of the ELSO 📆 Plenary Day 1, September 29 from 8 am 🎶 A musical tribute to Dr. Bartlett 🎤 Bartlett lecture 💡 Spirit of innovation: the Bartlett legacy 🎥 Bartlett celebration of life video & commentary 📌 Nashville, TN 🖇️ bit.ly/ELSO2026

021